Welcome to our dedicated page for Goodrx Holdings news (Ticker: GDRX), a resource for investors and traders seeking the latest updates and insights on Goodrx Holdings stock.
GoodRx Holdings, Inc. (NASDAQ: GDRX) is widely described as the leading platform for medication savings in the U.S., and its news flow reflects that role at the intersection of digital healthcare, pharmacy, and pharmaceutical manufacturers. Company announcements highlight new partnerships, product launches, and financial updates that shape how consumers, pharmacies, and manufacturers approach prescription affordability.
News about GoodRx often covers collaborations with major healthcare players. Examples include the RxSmartSaver program powered by GoodRx at national and regional retail pharmacies, which brings brand medication savings directly to the pharmacy counter, and an exclusive partnership with Surescripts that integrates GoodRx discounted cash prices into Script Corner, a patient experience product focused on prescription price transparency.
GoodRx also issues press releases on new consumer offerings and subscriptions. Recent updates describe GoodRx for Weight Loss, a telemedicine subscription for GLP-1 weight management treatment, and GoodRx for Hair Loss, a subscription program for men that combines virtual consultations, prescriptions for oral finasteride or oral minoxidil when appropriate, and discreet home delivery. Additional news highlights defined cash prices for medications such as Repatha, Ozempic, Wegovy, and the Wegovy pill at tens of thousands of pharmacies nationwide via GoodRx.
Investors and observers can also find earnings-related news, including quarterly financial results, guidance commentary, and participation in healthcare conferences. Together, these updates provide insight into GoodRx’s strategy across prescription transactions, subscriptions, pharma manufacturer solutions, and telehealth. For anyone tracking GDRX, this news page offers a focused view of how the company is evolving its platform, expanding partnerships, and addressing medication affordability across the U.S. healthcare system.
GoodRx Holdings, Inc. (Nasdaq: GDRX) announced that its management will present virtually at the Bank of America SMID Cap Ideas Conference on August 10 at 8:20 a.m. Pacific Time. A live webcast will be accessible on the Company’s Investor Relations website, with an archived recording available for 30 days after the event. GoodRx, a leading digital healthcare platform, has helped consumers save over $40 billion since 2011 and is among the most downloaded medical apps.
GoodRx Holdings Inc. (GDRX) will release its second quarter 2022 financial results on August 8, 2022, after U.S. market close. A conference call is scheduled for the same day at 2:00 PM PT (5:00 PM ET) to discuss the results and the company’s outlook. Investors can access the call by pre-registering via a provided link. GoodRx, a leading digital healthcare platform, has saved consumers over $40 billion since 2011, highlighting its role in making healthcare affordable for Americans.
GoodRx, a digital healthcare platform, announced a strategic partnership with RxVantage to enhance provider access to pharmaceutical resources. The integration aims to streamline connections between over 700,000 healthcare providers and drug manufacturers, addressing the administrative burdens faced by providers when accessing medication information. This initiative is expected to improve patient outcomes by facilitating timely communication regarding therapies and support programs. GoodRx has saved consumers over $35 billion since its inception in 2011.
GoodRx Holdings, Inc. (GDRX) reported its first quarter 2022 financial results, showcasing its role as a top consumer-focused digital healthcare platform. The company has significantly aided Americans, delivering over $35 billion in savings since its inception in 2011. A conference call is set for May 9, 2022, at 2:00 PM PT to elaborate on the results and future business outlook. The company is committed to making healthcare affordable and accessible across the U.S., supported by its technology and highly downloaded mobile app.
GoodRx (GDRX) has announced significant leadership changes to enhance its operations and drive innovation in the healthcare sector. Raj Beri joins as COO from Uber, while Mark Hull becomes the first Chief Product Officer, bringing extensive experience from Meta and LinkedIn. Vina Leite steps in as Chief People Officer, focusing on talent management, and Scott Paul is appointed Senior Vice President of Healthcare & Consumer Innovation. These appointments aim to strengthen the company's mission of providing affordable and accessible healthcare solutions.
GoodRx Holdings (Nasdaq: GDRX) has announced that its executives will present at the RBC Capital Markets 2022 Global Healthcare Conference in New York, NY, on May 17, at 1:35 p.m. ET. A live webcast will be available on their Investor Relations website, with an archived recording accessible for 30 days post-conference. GoodRx is recognized for providing significant savings and access to affordable healthcare, having saved consumers over $35 billion since its inception in 2011.
Relay Robotics, Inc. announces a successful $10 million Series A financing and has acquired Savioke, enhancing its robotic service offerings. Michael O'Donnell has been appointed as Chairman & CEO, with Savioke's co-founder, Steve Cousins, becoming CTO. The Relay robots, deployed at major hotels and healthcare facilities, aim to leverage the growing hospitality market projected to reach $6.7 trillion by 2026. Relay Robotics focuses on integrating AI to address labor shortages in service industries while enhancing operational efficiencies.
GoodRx (GDRX) announces a collaboration with AssistRx to enhance access to specialty medication therapy and streamline medication initiation. This partnership aims to address delays in patient care caused by prior authorization processes, which currently average 14-20 days. With 93% of physicians reporting care delays due to such requirements, GoodRx intends to leverage its provider network to promote AssistRx's iAssist platform, facilitating real-time access to patient benefits and prior authorization information. The collaboration reflects GoodRx's commitment to improving healthcare efficiency and affordability.
TherapeuticsMD (NASDAQ: TXMD) has successfully completed the $150 million divestiture of vitaCare Prescription Services to GoodRx (NASDAQ: GDRX). This strategic move, initially announced on March 6, 2022, allows TXMD to concentrate on its women's health portfolio. The company could also receive an additional $7 million based on vitaCare's 2023 financial performance. CEO Hugh O’Dowd emphasized the importance of this transaction in enhancing value for shareholders and patients.
GoodRx (GDRX) has completed its acquisition of vitaCare for $150 million in cash, plus an additional $7 million contingent on vitaCare's financial performance. This acquisition enhances GoodRx's capabilities in assisting pharmaceutical manufacturers and improving patient access to affordable medications. The deal is expected to strengthen GoodRx's Pharma Manufacturer Solutions, improving patient adherence to prescribed therapies. The company plans to address the financial impact of this acquisition during its upcoming earnings call on May 9, 2022.